CG Oncology, Inc.
CGON
$42.61
$1.243.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.81% | 19.57% | 21.52% | 295.37% | -- |
| Total Receivables | 275.91% | 208.79% | 125.49% | 748.91% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 20.28% | 5.68% | 3.88% | 79.79% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.03% | 19.36% | 21.19% | 288.52% | 163.26% |
|
|
|||||
| Total Current Assets | 26.03% | 19.36% | 21.19% | 288.52% | 163.26% |
| Net Property, Plant & Equipment | 5,678.70% | 194.92% | 191.46% | 0.41% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 115.09% | 51,215.09% | 48,375.47% | -97.99% | -- |
| Total Assets | 32.12% | 24.30% | 25.74% | 278.72% | 160.74% |
|
|
|||||
| Total Accounts Payable | 125.54% | 58.65% | 44.50% | 101.02% | -- |
| Total Accrued Expenses | 76.63% | 224.95% | 214.57% | 47.01% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 305.33% | 21.52% | 15.91% | -14.29% | -- |
| Total Finance Division Other Current Liabilities | 263.35% | 83.97% | 70.57% | -60.93% | -- |
| Total Other Current Liabilities | 263.35% | 83.97% | 70.57% | -60.93% | -- |
| Total Current Liabilities | 95.32% | 156.31% | 126.78% | 49.91% | 33.56% |
|
|
|||||
| Total Current Liabilities | 95.32% | 156.31% | 126.78% | 49.91% | 33.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4,588.73% | 498.31% | 324.46% | -78.69% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 169.22% | 159.69% | 130.36% | 47.61% | 30.65% |
|
|
|||||
| Common Stock & APIC | 41.82% | 34.27% | 33.72% | 13,804.68% | -- |
| Retained Earnings | -81.36% | -77.26% | -71.87% | -67.75% | -63.57% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 28.11% | 21.36% | 23.87% | 695.76% | 596.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.11% | 21.36% | 23.87% | 695.76% | 596.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.11% | 21.36% | 23.87% | 296.87% | -- |
|
|
|||||